Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ...
Greece had a minor impact on sales as it's not a key market. The focus is on Germany, Spain, and Italy. Market access activities will continue in smaller markets, with the Netherlands on hold. Progress in Italy is in the negotiation phase.